pharmaphorum

OCTOBER 12, 2018

Digital technology is transforming the way that healthcare is practiced and delivered, with areas like digital therapeutics forging ahead to complement traditional medical approaches and augment patient care. The development of software applications that are available with a prescription took a major step forward last year with the first FDA approval for a mobile medical application with both a safety and efficacy label.

Labelling 52

Labelling Communication Patient Care FDA 52

Med Ed 101

OCTOBER 10, 2018

What the heck is HLA B*5701? Let’s start with the HLA. HLA stands for human leukocyte antigen. The rest of the name is simply indicating that it is subtype of HLA. There are many different subtypes of HLA as mentioned with each specific medication below. You might be thinking, what does this have to do with […]. The post HLA B*5701 and the Rest – 3 Medications With Clinical Impact appeared first on Med Ed 101.

40

40

pharmaphorum

OCTOBER 11, 2018

Change Together will be presenting a live webinar with leading figures from the patient advocacy community, who will discuss communication and engagement as well as the different approaches advocacy groups can take to address the unique challenges of their communities. This will be helpful for all advocates, as we hear and learn from our expert panel how their organizations are bringing about change.

Communication 52

Communication 52

pharmaphorum

OCTOBER 9, 2018

Now more than ever before, Biotech is the engine for innovation in medicine, finding, creating and delivering ground-breaking treatments to patients. The journey from molecule discovery and development through valuation, funding, regulatory and commercialisation can be a long and complex road to travel though. These companies have to navigate a rapidly changing and increasingly complex landscape from pre-clinical valuation through foresight and planning at every stage of the asset life cycle - a

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.